1. Discovery of potential targets of Triptolide through inverse docking in ovarian cancer cells
   Qinhang Wu et al, 2020, PeerJ CrossRef
2. A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes
   Jing Song et al, 2023, Biomedicine & Pharmacotherapy CrossRef
3. Triptolide impairs genome integrity by directly blocking the enzymatic activity of DNA-PKcs in human cells
   Bailian Cai et al, 2020, Biomedicine & Pharmacotherapy CrossRef
4. Exploring the Therapeutic Potential of Triptonide in Salivary Adenoid Cystic Carcinoma: A Comprehensive Approach Involving Network Pharmacology and Experimental Validation
   Shikai Geng et al, 2024, Current Pharmaceutical Design CrossRef
5. Triptolide Shows High Sensitivity and Low Toxicity Against Acute Myeloid Leukemia Cell Lines Through Inhibiting WSTF-RNAPII Complex
   Di Kang et al, 2022, Frontiers in Oncology CrossRef
6. RETRACTED: Long non-coding RNA TUG1 alleviates LPS-induced injury of PC-12 cells by down-regulating microRNA-127
   Huajiang Zheng et al, 2019, Experimental and Molecular Pathology CrossRef
7. Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells
   Francisco Alejandro Lagunas-Rangel et al, 2020, Frontiers in Oncology CrossRef
8. Targeting the DNA damage response (DDR) of cancer cells with natural compounds derived from Panax ginseng and other plants
   SeokGyeong Choi et al, 2024, Journal of Ginseng Research CrossRef
9. The roles of TPL in hematological malignancies
   Tingyun Xu et al, 2023, Hematology CrossRef
10. RETRACTED: Triptolide inhibits viability and migration while promotes apoptosis in nephroblastoma cells by regulation of miR-193b-3p
    Shiying Hang et al, 2019, Experimental and Molecular Pathology CrossRef